High mobility group box 1 induced human lung myofibroblasts differentiation and enhanced migration by activation of MMP-9.
High mobility group box 1 induced human lung myofibroblasts differentiation and enhanced migration by activation of MMP-9.
复制标题
DOI:
10.1371/journal.pone.0116393
复制
发表时间:
2015
期刊:
影响因子:
3.7
通讯作者:
Liu JJ
中科院分区:
文献类型:
--
作者:
Lee CC;Wang CN;Lee YL;Tsai YR;Liu JJ
High mobility group box 1 (HMGB1) is a nuclear protein that involves the binding with DNA and influences chromatin regulation and transcription. HMGB1 is also a cytokine that can activate monocytes and neutrophils involved in inflammation. In this study, we investigated the role of HMGB1 on cellular activation using human fibroblast cell line WI-38. After treatment with 1, 10, and 100 ng/mL of HMGB1 for 24 h, we did not find obviously cytotoxicity and cellular proliferation of WI-38 cells by MTT and BrdU incorporation assay, respectively. However, we found that treatment with 10 and 100 ng/mL of HMGB1 induced the differentiation of lung fibroblasts into myofibroblasts and myofibroblasts showed higher migration ability through activation of matrix metalloproteinase (MMP)-9 activation. To delineate the mechanism underlying HMGB1-induced cellular migration, we examined HMGB1-induced mitogen activated protein kinases (MAPKs), including extracellular signal related kinase (ERK), c-Jun N-terminal kinase (JNK), and p38 mitogen activated protein kinase (p38) phosphorylation, as well as nuclear factor (NF)-κB nuclear translocation. Using specific inhibitors and shRNAs of protein kinases, we observed that repression of ERK, JNK, p38, and NF-κB all inhibited HMGB1-induced cellular differentiation, migration and MMP-9 activation in WI-38 cells. In addition, knocking down of RAGE but not TLR2 and TLR4 by shRNAs attenuated HMGB1-induced myofibroblast differentiation and migration. In conclusion, our study demonstrated that HMGB1 induced lung fibroblasts’ differentiation into myofibroblasts and enhanced cell migration through induction of MMP-9 activation and the RAGE-MAPK and NF-κB interaction signaling pathways. Targeting HMGB1 might be a potential therapeutic approach for alleviation of airway remodeling seen in chronic airway inflammatory diseases.
登录
查看更多内容
DOI:
10.1165/rcmb.2007-0330oc
发表时间:
2008-10-01
影响因子:
6.4
作者:
Hamada, Naoki;Maeyama, Takashige;Nakanishi, Yoichi
通讯作者:
Nakanishi, Yoichi
影响因子:
6.1
作者:
Lee, Chen-Chen;Wang, Chien-Neng;Lai, Yu-Ting
通讯作者:
Lai, Yu-Ting
影响因子:
6.1
作者:
Lee, Chen-Chen;Kang, Jaw-Jou;Cheng, Yu-Wen
通讯作者:
Cheng, Yu-Wen
影响因子:
5.5
作者:
Park, JS;Arcaroli, J;Abraham, E
通讯作者:
Abraham, E
影响因子:
3.2
作者:
Lee, Chen-Chen;Huang, Shih-Hsuan;Kang, Jaw-Jou
通讯作者:
Kang, Jaw-Jou